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ScienceDirectSince the revitalization of ‘the Warburg effect’, there has been
great interest in mitochondrial oxidative metabolism, not only
from the cancer perspective but also from the general
biomedical science field. As the center of oxidative
metabolism, mitochondria and their metabolic activity are
tightly controlled to meet cellular energy requirements under
different physiological conditions. One such mechanism is
through the inducible transcriptional co-regulators PGC1a and
NCOR1, which respond to various internal or external stimuli to
modulate mitochondrial function. However, the activity of such
co-regulators depends on their interaction with transcriptional
factors that directly bind to and control downstream target
genes. The nuclear receptors PPARs and ERRs have been
shown to be key transcriptional factors in regulating
mitochondrial oxidative metabolism and executing the
inducible effects of PGC1a and NCOR1. In this review, we
summarize recent gain-of-function and loss-of-function studies
of PPARs and ERRs in metabolic tissues and discuss their
unique roles in regulating different aspects of mitochondrial
oxidative metabolism.
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Introduction
Energy is vital to all living organisms. In humans and
other mammals, the vast majority of energy is produced
by oxidative metabolism in mitochondria [1]. As a cellular
organelle, mitochondria are under tight control of the
nucleus. Although the majority of mitochondrial proteins
are encoded by nuclear DNA (nDNA) and their expres-
sion regulated by the nucleus, mitochondria retain their
own genome, mitochondrial DNA (mtDNA), encoding
13 polypeptides of the electron transport chain (ETC) inwww.sciencedirect.com mammals. However, all proteins required for mtDNA
replication, transcription, and translation, as well as factors
regulating such activities, are encoded by the nucleus [2].
The cellular demand for energy varies in different cells
under different physiological conditions. Accordingly, the
quantity and activity of mitochondria are differentially
controlled by a transcriptional regulatory network in both
the basal and induced states. A number of components of
this network have been identified, including members of
the nuclear receptor superfamily, the peroxisome prolif-
erator-activated receptors (PPARs) and the estrogen-
related receptors (ERRs) [3–5].
The Yin-Yang co-regulators
A well-known inducer of mitochondrial oxidative metab-
olism is the peroxisome proliferator-activated receptor g
coactivator 1a (PGC1a) [6], a nuclear cofactor which is
abundantly expressed in high energy demand tissues such
as heart, skeletal muscle, and brown adipose tissue (BAT)
[7]. Induction by cold-exposure, fasting, and exercise
allows PGC1a to regulate mitochondrial oxidative metab-
olism by activating genes involved in the tricarboxylic
acid cycle (TCA cycle), beta-oxidation, oxidative phos-
phorylation (OXPHOS), as well as mitochondrial bio-
genesis [6,8] (Figure 1).
The effect of PGC1a on mitochondrial regulation is
antagonized by transcriptional corepressors such as the
nuclear receptor corepressor 1 (NCOR1) [9,10]. In con-
trast to PGC1a, the expression of NCOR1 is suppressed
in conditions where PGC1a is induced such as during
fasting, high-fat-diet challenge, and exercise [9,11].
Moreover, the knockout of NCOR1 phenotypically
mimics PGC1a overexpression in regulating mitochon-
drial oxidative metabolism [9]. Therefore, coactivators
and corepressors collectively regulate mitochondrial
metabolism in a Yin-Yang fashion.
However, both PGC1a and NCOR1 lack DNA binding
activity and rather act via their interaction with transcription
factors that direct the regulatory program. Therefore the
transcriptional factors that partner with PGC1a and NCOR1
mediate the molecular signaling cascades and execute their
inducible effects on mitochondrial regulation.
PPARs: master executors controlling fatty
acid oxidation
Both PGC1a and NCOR1 are co-factors for the peroxi-
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PPARs and ERRs are major executors of PGC1a-induced regulation of oxidative metabolism. Physiological stress such as exercise induces both
the expression and activity of PGC1a, which stimulates energy production by activating downstream genes involved in fatty acid and glucose
metabolism, TCA cycle, b-oxidation, OXPHOS, and mitochondrial biogenesis. The transcriptional activity of PGC1a relies on its interactions with
transcriptional factors such as PPARs (for controlling fatty acid metabolism) and ERRs (for regulating mitochondrial OXPHOS).[7,11–13]. It is now clear that all three PPARs play
essential roles in lipid and fatty acid metabolism by
directly binding to and modulating genes involved in
fat metabolism [13–19]. While PPARg is known as a
master regulator for adipocyte differentiation and does
not seem to be involved with oxidative metabolism
[14,20], both PPARa and PPARd are essential regulators
of fatty acid oxidation (FAO) [3,13,15,19,21] (Figure 1).
PPARa was first cloned as the molecular target of fibrates,
a class of cholesterol-lowering compounds that increase
hepatic FAO [22]. The importance of PPARa in regulat-
ing FAO is indicated in its expression pattern which is
restricted to tissues with high capacity of FAO such as
heart, liver, BAT, and oxidative muscle [23]. On the other
hand, PPARd is ubiquitously expressed with higher levels
in the digestive tract, heart, and BAT [24]. In the past
15 years, extensive studies using gain-of-function and
loss-of-function models have clearly demonstrated
PPARa and PPARd as the major drivers of FAO in a
wide variety of tissues.
Heart
The adult heart relies heavily on FAO as the energy
source. PPARa plays an important role in regulating
cardiac FAO. However, it only activates genes in FA
metabolic pathways such as fatty acid uptake and beta-
oxidation, rather than in the TCA cycle or OXPHOS [15].Current Opinion in Cell Biology 2015, 33:49–54 Notably, PPARa activation suppresses mitochondrial
OXPHOS genes that are regulated by PGC1a and ERRs
in cardiomyocytes [25]. When ectopically expressed in
the heart, PPARa induces cellular FA uptake and beta-
oxidation while reducing glucose import and glycolysis
[15]. However, the increased FA uptake seems to exceed
the burning capacity of mitochondrial OXPHOS, result-
ing in myocardial lipid accumulation and cardiac hyper-
trophy [15]. Knockout of PPARa leads to reduced FA
uptake and beta-oxidation [26], further confirming its
importance in regulating FAO.
PPARd shares certain similarities with PPARa in regulat-
ing FAO in the heart [16]. When overexpressed, PPARd
also induces FAO by up-regulating genes in mitochon-
drial FA transport and beta-oxidation. But unlike PPARa,
overexpression of PPARd does not cause lipid accumu-
lation or cardiac dysfunction, likely due to increased
glucose utilization [19]. The importance of PPARd in
regulating cardiac FAO has been further demonstrated in
a loss-of-function study, where heart-specific deletion of
PPARd causes down-regulation of key FAO genes and
reduces FAO, resulting in myocardial lipid accumulation
and cardiac hypertrophy [27].
Skeletal muscle
Skeletal muscle also burns fatty acids for energy pro-
duction. There are generally two types of muscle fibers:www.sciencedirect.com
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predominantly powered by oxidation of glucose and FA;
and type II glycolytic fibers that contain less mitochondria
and heavily rely on glycolysis for energy [28].
Both PPARa and PPARd play important roles in regulat-
ing muscle FAO. Overexpression of either in muscle
induces FAO by up-regulating genes involved in fatty
acid utilization and beta-oxidation [17,18,29,30]. How-
ever, PPARa overexpression also promotes a fiber-type
transition toward more glycolytic fibers which have lower
mitochondrial OXPHOS activity. This induces lipid
accumulation and drives the development of glucose
intolerance and insulin resistance [18,30]. PPARa
deletion, on the other hand, increases the number of
oxidative fibers and improves glucose homeostasis,
despite the reduction in muscle FAO [18,30].
In contrast to PPARa, overexpression of PPARd does not
cause lipid accumulation or glucose intolerance [17,29].
In addition to induced FAO, PPARd also increases the
proportion of oxidative fibers that are rich in mitochon-
dria, thus dramatically boosting mitochondrial oxidative
metabolism. This is associated with 90% increase in
endurance capacity and resistance against diet-induced
diabetes [17,30]. Conversely, muscle-specific PPARd
depletion leads to an oxidative-to-glycolytic fiber-type
switch with reduced FAO and OXPHOS. The mutant
mice gain more weight on high fat diet and are more
susceptible to insulin resistance [31].
The ability of PPARa and PPARd to transform fiber
types in opposite directions seem to be mediated by
two microRNAs, miR-208b and miR-499 [30], which
directly activate the oxidative and repress the glycolytic
myofibril gene program [32].
Liver
In the liver PPARa is the predominant PPAR isoform
[24]. It is essential in regulating hepatic FA uptake, beta-
oxidation, and ketogenesis, especially during fasting.
PPARa knockout suppresses the expression of genes
involved in FA uptake and FAO, resulting in decreased
basal-state hepatic FA uptake and beta-oxidation [33]. In
addition, fasting-induced hepatic responses, including
elevated FA oxidation, gluconeogenesis, and ketogenesis,
are all impaired in PPARa-null mice. As a result, the
fasted mutant mice develop hypoketogenesis, hypogly-
cemia, and liver steatosis [26,34].
PPARd seems to play a different role in regulating hepatic
energy metabolism. Unlike PPARa, PPARd deletion
reduces the expression of genes involved in lipogenesis
and glucose utilization instead of FA metabolism. More-
over, fasted PPARd-null mice have a normal ketogenic
response, increased serum glucose levels and no sign of
liver steatosis [35]. When overexpressed in the liver,www.sciencedirect.com PPARd increases hepatic glycogen and lipid storage as
a result of up-regulation of genes in glucose utilization
and lipogenesis [36]. In addition, hepatic PPARd acti-
vates muscle FA oxidation through a lipid molecule PC
(18:0/18:1), which is produced by a PPARd-dependent
lipogenic pathway [37].
Fat
PPARa is highly expressed in BAT but not in white
adipose tissue (WAT) [24]. Its primary function in BAT
seems to be the regulation of PGC1a and UCP1 (a
mitochondrial uncoupling protein) expression. PPARa
deletion reduces expression of PGC1a and UCP1 under
both basal and cold-exposure conditions [21,38]. How-
ever, unlike in other tissues, FA metabolism in BAT is not
affected by PPARa knockout, suggesting the contri-
bution of other PPARs [39]. When activated in human
and mouse adipocytes, PPARa induces the expression of
FAO genes and increases energy expenditure [40,41].
PPARd is expressed in both BAT and WAT. While its
function in WAT is unknown, it is clear that PPARd plays
an essential role in regulating FA oxidation and thermo-
genesis in BAT [13,42,43]. When ectopically expressed in
adipose tissue, PPARd dramatically induces the expres-
sion of genes in FAO, OXPHOS, and thermogenesis,
which results in increased FAO in BAT, reduced systemic
adiposity and improved serum lipid profiles [13,44]. Con-
versely, deletion of PPARd in BAT reduces the expres-
sion of FAO and thermogenic genes, which impairs in vivo
thermogenesis [13,43].
ERRS: master executors controlling
mitochondrial OXPHOS
ERRs are essential regulators of mitochondrial energy
metabolism [4]. ERRa is ubiquitously expressed but
particularly abundant in tissues with high energy demands
such as brain, heart, muscle, and BAT. ERRb and ERRg
have similar expression patterns, both are selectively
expressed in highly oxidative tissues including brain, heart,
and oxidative muscle [45]. Instead of endogenous ligands,
the transcriptional activity of ERRs is primarily regulated by
co-factors such as PGC1a and NCOR1 [4,46] (Figure 1).
Of the three ERRs, ERRb is the least studied and its role in
regulating mitochondrial function is unclear [4,47]. In
contrast, when PGC1a is induced, ERRa is the master
regulator of the mitochondrial biogenic gene network. As
ERRa binds to its own promoter, PGC1a can also induce
an autoregulatory loop to enhance overall ERRa activity
[48]. Without ERRa, the ability of PGC1a to induce the
expression of mitochondrial genes is severely impaired.
However, the basal-state levels of mitochondrial target
genes are not affected by ERRa deletion, suggesting
induced mitochondrial biogenesis is a transient process
and that other transcriptional factors such as ERRg may be
important maintaining baseline mitochondrial OXPHOSCurrent Opinion in Cell Biology 2015, 33:49–54
52 Cell regulation[41,42,43]. Consistent with this idea, ERRg (which is
active even when PGC1a is not induced) shares many
target genes with ERRa [49,50].
Genome-wide analysis of ERRa and ERRg has con-
firmed their direct and overlapping binding in promoter
regions of a large number of mitochondrial genes, many of
which are PGC1a targets [8,49]. These genes cover many
aspects of mitochondrial oxidative metabolism, ranging
from glucose utilization, FA oxidation, the TCA cycle,
and OXPHOS. About a quarter of the binding sites are
shared by both ERRs, indicating their cooperative regu-
lation of those genes. Recently several gain-of-function
and loss-of-function studies have revealed a better un-
derstanding of their in vivo roles [44–50].
Heart
Both ERRa and ERRg are highly expressed in the heart
[45]. Knockout of ERRa causes down-regulation of a
number of genes in mitochondrial oxidative metabolism,
some of which are direct ERRa targets. Interestingly,
another set of genes in mitochondrial oxidative metab-
olism, including PGC1a and ERRg, are up-regulated by
ERRa deletion, indicating a compensatory effect of
ERRg [49]. The ERRa-null heart only shows minimal
defects with normal mitochondrial function in the basal
state. However, when challenged with pressure overload
(a common method to induce cardiac hypertrophy), the
knockout mice exhibit more severe phenotypes with
dilated hypertrophy and early heart failure, possibly
due to a defect in energy reserve, indicating the require-
ment of ERRa during stressed conditions [51].
Similar to ERRa, ERRg deletion also causes both down-
regulation and up-regulation of genes in mitochondrial
oxidative metabolism, as well as up-regulated PGC1a and
ERRa. The altered expression of OXPHOS genes causes
severe mitochondrial defects: increased mtDNA copy
number, reduced ETC complex I activity, and increased
complex IV activity. As a result, most ERRg-null mice die
within the first week of their life due to heart failure [50].
Skeletal muscle
ERRa is uniformly expressed in both oxidative and
glycolytic muscles [52]. The knockout of ERRa in
skeletal muscle causes no phenotypic change in the basal
state [53,54]. However, in a cardiotoxin induced injury
model, its deficiency reduces mitochondrial activity and
impairs muscle regeneration [54].
Unlike ERRa, ERRg is selectively expressed in oxi-
dative muscle [52]. When ectopically expressed in
glycolytic muscle, ERRg drives a fiber-type switch from
glycolytic to oxidative fibers, with dramatically induced
mitochondrial biogenesis and vascularization. This is
accompanied by the induction of genes in pathways such
as FA oxidation, TCA cycle, and OXPHOS, many ofCurrent Opinion in Cell Biology 2015, 33:49–54 which are direct ERR targets [49,52,55]. However,
whether ERRg is required for basal-sate mitochondrial
function in oxidative muscle remains unclear.
Fat
Both ERRa and ERRg are expressed higher in BAT than
in WAT [45]. While the role of ERRg in fat is still under
investigation, ERRa seems to be required in regulating
stress-induced metabolism in both WAT and BAT.
Whole-body knockout of ERRa causes reduced fat mass
which becomes more striking when challenged with a
high-fat diet. The ERRa-null WAT has altered expres-
sion of metabolic genes including direct ERR targets [56].
When challenged with cold-exposure, the mutant mice
display impaired thermogenesis, accompanied by
decreased mitochondrial biogenesis and increased lipid
accumulation in BAT. Gene expression analysis reveals
repression of mitochondrial oxidative metabolism genes,
many of which are direct ERR targets [57].
Therefore, ERRa and ERRg cooperatively regulate oxi-
dative metabolism by directly controlling the expression
of genes in this pathway. Despite their shared target
genes, each appears to have its own unique function,
with ERRa more involved in stress-induced responses
and ERRg required for maintaining the baseline mito-
chondrial integrity.
Conclusion and perspectives
Taken together, recent studies have clearly demonstrated
the essential roles of PPARs and ERRs in regulating
mitochondrial oxidative metabolism and executing the
inducible effects of PGC1a (Figure 1). Both PPARa and
PPARd are key regulators for FA oxidation. While the
function of PPARa seems more restricted in FA uptake,
beta-oxidation, and ketogenesis, PPARd plays a broader
role in controlling oxidative metabolism and fuel prefer-
ence, with its target genes involved in FA oxidation, mito-
chondrial OXPHOS, and glucose utilization. However, it is
still not clear how much redundancy exists between PPARa
and PPARd, a question which may require the generation of
a double knockout model. In addition, more effort is needed
to fully understand how PPARa and PPARd control their
target genes in response to environmental changes.
Likewise, ERRa and ERRg have been shown to be key
regulators of mitochondrial OXPHOS. Knockout studies
of ERRa suggest it to be the principal executor of PGC1a
induced up-regulation of mitochondrial genes, though its
role in exercise-dependent changes in skeletal muscle
needs further investigation. Transgenic models have
demonstrated ERRg’s powerful induction of mitochon-
drial biogenesis and its ability to act in a PGC1a-inde-
pendent manner. However, it remains to be elucidated
whether ERRg is sufficient for basal-state mitochondrial
function in general, and whether ERRa can compensate
for its function.www.sciencedirect.com
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